CAS No. :	35943-35-2
Formula :	C₁₃H₁₆N₆O₄
M.W :	320.30
SMILES Code :	NC1=NN(C)C2=NC=NC3=C2C1=CN3[C@H]4[C@@H]([C@@H]([C@@H](CO)O4)O)O
Synonyms :	API-2; TCN; Tricyclic Nucleoside
MDL No. :	MFCD00932413
InChI Key :	HOGVTUZUJGHKPL-HTVVRFAVSA-N
Pubchem ID :	65399

GHS Pictogram:
Signal Word:	Warning
Hazard Statements:	H317-H319
Precautionary Statements:	P280-P305+P351+P338

SUM159 cells	20 μM	3 h	Inhibition of Akt activity, reduction of Runx2 target gene expression	J Cell Physiol. 2013 Aug;228(8):1784-92.
Caco2 cells	1 μM	60 min	To study the effect of Triciribine on Ang II-induced inhibition of Pgp activity, results showed that Triciribine blocked the inhibitory effect of Ang II on Pgp activity.	Acta Physiol (Oxf). 2020 Jan;228(1):e13332.
Mouse cardiac fibroblasts (MCF)	1 µM or 10 µM	6 days	Triciribine was able to abolish the effect of circ-Amotl1 on promoting MCF cell proliferation.	Theranostics. 2017 Aug 29;7(16):3842-3855.
Mouse cardiac fibroblasts (MCF)	1 µM	3 days	1 µM Triciribine was able to abolish the effect of circ-Amotl1 on promoting MCF cell proliferation after 3 days.	Theranostics. 2017 Aug 29;7(16):3842-3855.
Mouse cardiac fibroblasts (MCF)	0.1 µM	3 days	0.1 µM Triciribine was able to abolish the effect of circ-Amotl1 on repressing MCF cell apoptosis after 3 days.	Theranostics. 2017 Aug 29;7(16):3842-3855.
Adipoq−/− VSMCs	10 µM	24 h	Inhibition of AKT and MAPK1 signaling pathways, reducing cell proliferation and migration, and partially restoring the contractile phenotype of VSMCs.	Cells. 2023 Oct 20;12(20):2493.
Caco2 cells	1 μM	1 h	Triciribine blocked the inhibitory effects of Ang II on Pgp function, indicating that Akt plays a key role in Ang II-mediated inhibition of Pgp function.	Acta Physiol (Oxf). 2020 Jan;228(1):e13332.
HNSCC cells	5 μM	24 h	Inhibition of AKT activation, significantly suppressed BDNF-mediated cellular motility	Oncogene. 2010 Apr 8;29(14):2047-59.

Mice	APAP-induced liver injury model	Intraperitoneal injection	1 mg/kg	Single dose, ALT measured at 24 hours post-APAP	Inhibition of Akt signaling aggravated APAP-induced liver injury	Hepatology. 2017 Nov;66(5):1601-1615
Mice	ARHGEF3-KO mice	Intraperitoneal injection	1 mg/kg	Every 24 hours until the end of the experiment	Triciribine inhibited the phosphorylation of Akt but did not prevent the enhanced muscle regeneration and strength recovery in ARHGEF3-KO mice, indicating that the promotion of muscle regeneration by ARHGEF3 knockout is independent of the Akt signaling pathway.	Cell Rep. 2021 Jan 5;34(1):108594

NCT02515773	Bipolar Disorder	Phase 4	Recruiting	October 2020	United States, Kentucky ... More >> The Children's Home of Northern Kentucky Recruiting Covington, Kentucky, United States, 41011 Contact: Joe Reiman 859-292-4122 jrieman@chnk.org United States, New Jersey Jersey Shore Medical Center Not yet recruiting Neptune City, New Jersey, United States, 07753 Contact: Nicholas Remo 732-776-3498 NRemo@meridianhealth.com United States, New York South Oaks Recruiting Amityville, New York, United States, 11701 Contact: Patricia Flaherty, LCSW-R,ACSW, 631-608-5222 pflaherty@northwell.edu SUNY Downstate/ Kings County Hospital Not yet recruiting Brooklyn, New York, United States, 11203 Contact: Cathryn A. Galanter, M.D. 718-245-2502 cathryn.galanter@downstate.edu Maimonides Not yet recruiting Brooklyn, New York, United States, 11219 Contact: George Alvarado, M.D. 718-283-8215 GAlvarado@maimonidesmed.org NYCCC Not yet recruiting Brooklyn, New York, United States, 11233 Contact: Eva Sheridan 718-470-4391 eschenk@northwell.edu Northwell Zucker Long Island Jewish Hospital Recruiting Glen Oaks, New York, United States, 11004 Contact: Arielle Carmel 718-470-8021 acarmel@northwell.edu Mount Sinai Recruiting New York, New York, United States, 10029 Contact: Julia G Jones 212-241-3692 julia.george-jones@mssm.edu LIJ Zucker Hillside Hospital Recruiting New York, New York, United States, 11004 Contact: Eva Shenck 718-470-4391 eschenk@northwell.edu Child Center of New York, Recruiting Queens, New York, United States, 11373 Contact: Isaiah Mui 718-358-8288 ext 221 isaiahmui@childcenterny.org Contact: Alla Weinstein 718.358.8288 allaweinstein@childcenterny.org NorthShore Child and Family Guidance Recruiting Roslyn Heights, New York, United States, 11577 Contact: Esther Gonzalez 516-626-1971 EGonzalez@northshorechildguidance.org StonyBrook Recruiting Stony Brook, New York, United States, 11794 Contact: Gabrielle A Carlson, MD 631-632-8840 Gabrielle.Carlson@stonybrookmedicine.edu United States, Ohio Lighthouse Youth Services Recruiting Cincinnati, Ohio, United States, 45206 Contact: Jody Harding 513-487-6778 jarding@lys.org Contact: Shannon Kiniyalocts 513-487-7706 skiniyalocts@lys.org Central Clinic Recruiting Cincinnati, Ohio, United States, 45219 Contact: Maria Piombo, Ed.D.,LPCC-S 513-558-5890 piombom@ucmail.uc.edu Children's Home Recruiting Cincinnati, Ohio, United States, 45227 Contact: Jessica Aritonovich 513-272-2800 ext 4352 jaritonovich@thechildrenshomecinti.org Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Elizabeth Picard, MS 513-803-8898 elizabeth.picard@cchmc.org Contact: Shelley Randall 513-803-2342 Shelley.randall@cchmc.org Resident Mood Medication Clinic Recruiting Cincinnati, Ohio, United States, 45229 Contact: Christy Klein, MPH 513-558-5746 kleinci@ucmail.uc.edu St. Aloysius Recruiting Cincinnati, Ohio, United States, 45237 Contact: Morrisa Gray, RN, BSN 513-482-7257 mgray@stalsorphanage.org Talbert House Recruiting Cincinnati, Ohio, United States, 45238 Contact: Sharon Stanford, MD 513-265-6090 sharon.stanford@talberthouse.com St. Joseph's Orphanage Recruiting Cincinnati, Ohio, United States, 45239 Contact: Tyann Godwin, RN 513-741-3100 ext 2166 tyann.godwin@sjokids.org Child Focus Recruiting Cincinnati, Ohio, United States, 45244 Contact: Jessica Bowlin JBowlin@child-focus.org NECCO Recruiting Cincinnati, Ohio, United States, 45246 Contact: Jessica Parks, MSM, LISW-S 513-771-9600 jparks@necco.org University Hospital Medical Center Cleveland Recruiting Cleveland, Ohio, United States, 44106 Contact: Elizabeth Deyling Elizabeth.Deyling@UHhospitals.org Nationwide Children's Hospital Columbus Recruiting Columbus, Ohio, United States, 43205 Contact: Raymond Troy raymond.troy@nationwidechildrens.org Ohio State University Recruiting Columbus, Ohio, United States, 43210 Contact: Ghada Lteif, MD 614-293-8237 ghada.lteif@osumc.edu South Community Recruiting Dayton, Ohio, United States Contact: Mary Day, RN 937-245-6121 mday@southcommunity.com Butler Behavioral Health Services Recruiting Hamilton, Ohio, United States, 45011 Contact: Randy Allman, LISW-S 513-881-7189 ext 3134 Rallman@bbhs.org TCN Family Solutions Recruiting Xenia, Ohio, United States, 45385 Contact: Carmel Flores 937-427-3837 cflores@tcn.org United States, Texas Seton Family of Hospitals Not yet recruiting Austin, Texas, United States, 78712 Contact: Ashleigh Smith AJSmith2@seton.org Less <<
NCT01098812	Cataract	Phase 3	Completed	-	United States, California ... More >> AMO Clinical Research Call Center for Trial Locations Santa Ana, California, United States, 92705 Less <<
NCT02332005	Diabetic Peripheral Neuropathy	Phase 2 Phase 3	Completed	-	Russian Federation ... More >> City Hospital No 40 of the Kurortny District St Petersburg, Sestroretsk, Russian Federation, 197706 Northern State Medical University Arkhangelsk, Russian Federation, 163000 Health Services Severstal Cherepovets, Russian Federation, 162600 Clinic of Neurology Ekaterinburg, Russian Federation, 620014 Kemerovo Regional Clinical Hospital Kemerovo, Russian Federation, 650066 Endocrinology Dispensary Moscow, Russian Federation, 119034 Morozovskaya Children City Hospital of Moscow Moscow, Russian Federation, 119049 I M Sechenov First Moscow State Medical University Moscow, Russian Federation, 119435 IM Sechenov First Moscow State Medical University Moscow, Russian Federation, 119435 IM Sechenov First Moscow State Medical University Moscow, Russian Federation, 119991 City Clinical Hospital No 71 Moscow, Russian Federation, 121374 Central Clinical Hospital No 1 of JSC Russian Railway Moscow, Russian Federation, 125367 City Clinical Hospital No 50 Moscow, Russian Federation, 127206 The Federal Bureau of Medical and Social Expertise Moscow, Russian Federation, 127486 Perm State Medical Academy Perm, Russian Federation, 614107 VA Baranov Respublical Hospital Petrozavodsk, Russian Federation, 185019 Rostov State Medical University Rostov-on-Don, Russian Federation, 344022 City Polyclinic No 20 Saratov, Russian Federation, 410053 Imc Sogaz St Petersburg, Russian Federation, 191186 Medical Center Reavita St Petersburg, Russian Federation, 194295 City Hospital of the Holy Martyr Elizabeth St Petersburg, Russian Federation, 195257 Nikolaev Hospital St Petersburg, Russian Federation, 198510 Bashkir State Medical University Ufa, Russian Federation, 450000 Central City Clinical Hospital Ulyanovsk, Russian Federation, 432057 State Medical University Volgograd, Russian Federation, 400131 Regional Clinical Hospital Yaroslavl, Russian Federation, 150000 NV Solovyov Clinical Emergency Hospital Yaroslavl, Russian Federation, 150003 Less <<
NCT03326713	Breast Cancer ... More >> Ovarian Cancer Less <<	Not Applicable	Recruiting	September 1, 2021	United States, New Mexico ... More >> University of New Mexico Recruiting Albuquerque, New Mexico, United States, 87131 Contact: Anita Y Kinney, PhD, RN 505-925-0731 AYKinney@salud.unm.edu Less <<
NCT01863290	-		Completed	-	United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States, 25294-4410 United States, California Contra Costa Health Services (East and West Contra Costa) Martinez, California, United States, 94553 Southeast Health Center San Francisco, California, United States, 94103 Santa Clara Health Center San Jose, California, United States, 95128 United States, Connecticut Yale Primary Care Center New Haven, Connecticut, United States, 06520 United States, Maryland East Baltimore Medical Center Baltimore, Maryland, United States, 21287 United States, Massachusetts Boston Healthcare for the Homeless Program Boston, Massachusetts, United States, 02118 United States, New York Morningside Clinic New York, New York, United States, 10025 Montefiore Transition Clinic New York, New York, United States, 10467 Medicine in Psychiatry Service clinic of the University of Rochester Medical Center Rochester, New York, United States, 14642 Puerto Rico Corporacion SANOS Caguas, Puerto Rico, 00725 Less <<
NCT02860013	Heart Failure	Not Applicable	Unknown	-	-
NCT00747565	Cataract	Not Applicable	Completed	-	-
NCT01098812	-		Completed	-	-
NCT01594437	Cytomegalovirus Infections	Phase 1	Completed	-	United States, Maryland ... More >> SNBL Clinical Pharmacology Center Baltimore, Maryland, United States, 21201 Less <<
NCT00747565	-		Completed	-	-
NCT01697293	Breast Adenocarcinoma ... More >> Estrogen Receptor Positive HER2/Neu Negative Recurrent Breast Carcinoma Stage IIB Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Less <<	Phase 1 Phase 2	Recruiting	January 2019	United States, Florida ... More >> Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Hyo S. Han 813-745-8480 hyo.han@moffitt.org Principal Investigator: Hyo S. Han United States, New York Albert Einstein College of Medicine Recruiting Bronx, New York, United States, 10461 Contact: Joseph A. Sparano 718-405-8404 jsparano@montefiore.org Principal Investigator: Joseph A. Sparano Less <<
NCT01984840	Pulmonary Disease, Chronic Obs... More >>tructive Less <<	Not Applicable	Completed	-	Denmark ... More >> Aalborg University Aalborg, Denmark, 9220 Less <<
NCT02930109	Acute Leukemia	Phase 1 Phase 2	Recruiting	December 2018	United States, Connecticut ... More >> Yale Cancer Center Recruiting New Haven, Connecticut, United States, 06520-8028 Contact: Anne Caldewell 475-434-7321 anne.caldwell@yale.edu Contact: Rebecca Lilian rebecca.lilian@yale.edu Principal Investigator: Thomas Prebet, MD United States, Florida Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Nancy Hillgruber nancy.hillgruber@moffitt.org Principal Investigator: Jeffrey Lancet, MD Less <<
NCT01390025	Influenza, Human	Phase 1	Completed	-	United States, Maryland ... More >> SNBL Clinical Pharmacology Center Baltimore, Maryland, United States, 21201 Less <<
NCT01719874	Influenza	Phase 2	Unknown	March 2013	United Kingdom ... More >> Recruiting London, United Kingdom Less <<
NCT01690468	Ovarian Cancer	Phase 1 Phase 2	Recruiting	December 2018	United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Denise Dorman 813-745-7272 denise.dorman@moffitt.org Sub-Investigator: Sachin Apte, M.D. Principal Investigator: Robert M. Wenham, M.D. Sub-Investigator: Mian Shahzad, M.D., Ph.D. Less <<
NCT00363454	Cancer	Phase 1	Completed	-	United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Insitute Tampa, Florida, United States, 33612 Less <<
NCT00642031	Hematologic Malignancies\|Leuke... More >>mia Less <<	PHASE1	COMPLETED	2025-10-12	H. Lee Moffitt Cancer Center, ... More >>Tampa, Florida, 33612, United States\|UT MD Anderson Cancer Center, Houston, Texas, 77030, United States Less <<

{[proInfo.proName]}

CAS No.: 35943-35-2

{[proInfo.proName]}

CAS No.: 35943-35-2

Alternative Products

Product Details of Triciribine

Safety of Triciribine

Related Pathways of Triciribine

Isoform Comparison

Biological Activity

Protocol

References

Historical Records

Categories

Precautionary Statements-General

Prevention

Response

Storage

Disposal

Physical hazards

Health hazards

Environmental hazards

Inquiry

Molarity Calculator

Total Compounds Calculator

Dissolution Calculator

Bio Calculators
Preparing Stock Solutions		1mg	5mg	10mg
Preparing Stock Solutions	1 mM 5 mM 10 mM	3.12mL 0.62mL 0.31mL	15.61mL 3.12mL 1.56mL	31.22mL 6.24mL 3.12mL
Dissolving Methods	Animal experiment Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn: in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound. Protocol 1 Protocol 2

Precautionary Statements-General
Code	Phrase
P101	If medical advice is needed,have product container or label at hand.
P102	Keep out of reach of children.
P103	Read label before use
Prevention
Code	Phrase
P201	Obtain special instructions before use.
P202	Do not handle until all safety precautions have been read and understood.
P210	Keep away from heat/sparks/open flames/hot surfaces. - No smoking.
P211	Do not spray on an open flame or other ignition source.
P220	Keep/Store away from clothing/combustible materials.
P221	Take any precaution to avoid mixing with combustibles
P222	Do not allow contact with air.
P223	Keep away from any possible contact with water, because of violent reaction and possible flash fire.
P230	Keep wetted
P231	Handle under inert gas.
P232	Protect from moisture.
P233	Keep container tightly closed.
P234	Keep only in original container.
P235	Keep cool
P240	Ground/bond container and receiving equipment.
P241	Use explosion-proof electrical/ventilating/lighting/equipment.
P242	Use only non-sparking tools.
P243	Take precautionary measures against static discharge.
P244	Keep reduction valves free from grease and oil.
P250	Do not subject to grinding/shock/friction.
P251	Pressurized container: Do not pierce or burn, even after use.
P260	Do not breathe dust/fume/gas/mist/vapours/spray.
P261	Avoid breathing dust/fume/gas/mist/vapours/spray.
P262	Do not get in eyes, on skin, or on clothing.
P263	Avoid contact during pregnancy/while nursing.
P264	Wash hands thoroughly after handling.
P265	Wash skin thouroughly after handling.
P270	Do not eat, drink or smoke when using this product.
P271	Use only outdoors or in a well-ventilated area.
P272	Contaminated work clothing should not be allowed out of the workplace.
P273	Avoid release to the environment.
P280	Wear protective gloves/protective clothing/eye protection/face protection.
P281	Use personal protective equipment as required.
P282	Wear cold insulating gloves/face shield/eye protection.
P283	Wear fire/flame resistant/retardant clothing.
P284	Wear respiratory protection.
P285	In case of inadequate ventilation wear respiratory protection.
P231 + P232	Handle under inert gas. Protect from moisture.
P235 + P410	Keep cool. Protect from sunlight.
Response
Code	Phrase
P301	IF SWALLOWED:
P304	IF INHALED:
P305	IF IN EYES:
P306	IF ON CLOTHING:
P307	IF exposed:
P308	IF exposed or concerned:
P309	IF exposed or if you feel unwell:
P310	Immediately call a POISON CENTER or doctor/physician.
P311	Call a POISON CENTER or doctor/physician.
P312	Call a POISON CENTER or doctor/physician if you feel unwell.
P313	Get medical advice/attention.
P314	Get medical advice/attention if you feel unwell.
P315	Get immediate medical advice/attention.
P320
P302 + P352	IF ON SKIN: wash with plenty of soap and water.
P321
P322
P330	Rinse mouth.
P331	Do NOT induce vomiting.
P332	IF SKIN irritation occurs:
P333	If skin irritation or rash occurs:
P334	Immerse in cool water/wrap n wet bandages.
P335	Brush off loose particles from skin.
P336	Thaw frosted parts with lukewarm water. Do not rub affected area.
P337	If eye irritation persists:
P338	Remove contact lenses, if present and easy to do. Continue rinsing.
P340	Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P341	If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P342	If experiencing respiratory symptoms:
P350	Gently wash with plenty of soap and water.
P351	Rinse cautiously with water for several minutes.
P352	Wash with plenty of soap and water.
P353	Rinse skin with water/shower.
P360	Rinse immediately contaminated clothing and skin with plenty of water before removing clothes.
P361	Remove/Take off immediately all contaminated clothing.
P362	Take off contaminated clothing and wash before reuse.
P363	Wash contaminated clothing before reuse.
P370	In case of fire:
P371	In case of major fire and large quantities:
P372	Explosion risk in case of fire.
P373	DO NOT fight fire when fire reaches explosives.
P374	Fight fire with normal precautions from a reasonable distance.
P376	Stop leak if safe to do so. Oxidising gases (section 2.4) 1
P377	Leaking gas fire: Do not extinguish, unless leak can be stopped safely.
P378
P380	Evacuate area.
P381	Eliminate all ignition sources if safe to do so.
P390	Absorb spillage to prevent material damage.
P391	Collect spillage. Hazardous to the aquatic environment
P301 + P310	IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P301 + P312	IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P301 + P330 + P331	IF SWALLOWED: Rinse mouth. Do NOT induce vomiting.
P302 + P334	IF ON SKIN: Immerse in cool water/wrap in wet bandages.
P302 + P350	IF ON SKIN: Gently wash with plenty of soap and water.
P303 + P361 + P353	IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower.
P304 + P312	IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell.
P304 + P340	IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing.
P304 + P341	IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338	IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P306 + P360	IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes.
P307 + P311	IF exposed: call a POISON CENTER or doctor/physician.
P308 + P313	IF exposed or concerned: Get medical advice/attention.
P309 + P311	IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician.
P332 + P313	IF SKIN irritation occurs: Get medical advice/attention.
P333 + P313	IF SKIN irritation or rash occurs: Get medical advice/attention.
P335 + P334	Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages.
P337 + P313	IF eye irritation persists: Get medical advice/attention.
P342 + P311	IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician.
P370 + P376	In case of fire: Stop leak if safe to Do so.
P370 + P378	In case of fire:
P370 + P380	In case of fire: Evacuate area.
P370 + P380 + P375	In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion.
P371 + P380 + P375	In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion.
Storage
Code	Phrase
P401
P402	Store in a dry place.
P403	Store in a well-ventilated place.
P404	Store in a closed container.
P405	Store locked up.
P406	Store in corrosive resistant/ container with a resistant inner liner.
P407	Maintain air gap between stacks/pallets.
P410	Protect from sunlight.
P411
P412	Do not expose to temperatures exceeding 50 oC/ 122 oF.
P413
P420	Store away from other materials.
P422
P402 + P404	Store in a dry place. Store in a closed container.
P403 + P233	Store in a well-ventilated place. Keep container tightly closed.
P403 + P235	Store in a well-ventilated place. Keep cool.
P410 + P403	Protect from sunlight. Store in a well-ventilated place.
P410 + P412	Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF.
P411 + P235	Keep cool.
Disposal
Code	Phrase
P501	Dispose of contents/container to ...
P502	Refer to manufacturer/supplier for information on recovery/recycling

Physical hazards
Code	Phrase
H200	Unstable explosive
H201	Explosive; mass explosion hazard
H202	Explosive; severe projection hazard
H203	Explosive; fire, blast or projection hazard
H204	Fire or projection hazard
H205	May mass explode in fire
H220	Extremely flammable gas
H221	Flammable gas
H222	Extremely flammable aerosol
H223	Flammable aerosol
H224	Extremely flammable liquid and vapour
H225	Highly flammable liquid and vapour
H226	Flammable liquid and vapour
H227	Combustible liquid
H228	Flammable solid
H229	Pressurized container: may burst if heated
H230	May react explosively even in the absence of air
H231	May react explosively even in the absence of air at elevated pressure and/or temperature
H240	Heating may cause an explosion
H241	Heating may cause a fire or explosion
H242	Heating may cause a fire
H250	Catches fire spontaneously if exposed to air
H251	Self-heating; may catch fire
H252	Self-heating in large quantities; may catch fire
H260	In contact with water releases flammable gases which may ignite spontaneously
H261	In contact with water releases flammable gas
H270	May cause or intensify fire; oxidizer
H271	May cause fire or explosion; strong oxidizer
H272	May intensify fire; oxidizer
H280	Contains gas under pressure; may explode if heated
H281	Contains refrigerated gas; may cause cryogenic burns or injury
H290	May be corrosive to metals
Health hazards
Code	Phrase
H300	Fatal if swallowed
H301	Toxic if swallowed
H302	Harmful if swallowed
H303	May be harmful if swallowed